相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels
Nehad M. Ayoub et al.
INVESTIGATIONAL NEW DRUGS (2021)
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance
Manendra Singh Tomar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Immune factors associated with the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer
Ryungsa Kim et al.
TRANSLATIONAL ONCOLOGY (2021)
Photoacoustic Computed Tomography of Breast Cancer in Response to Neoadjuvant Chemotherapy
Li Lin et al.
ADVANCED SCIENCE (2021)
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial
Monika Graeser et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
Elina A. Pietilae et al.
NATURE COMMUNICATIONS (2021)
bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses
Pascal Jezequel et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2021)
PINCH-1 interacts with myoferlin to promote breast cancer progression and metastasis
Tao Qian et al.
ONCOGENE (2020)
Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice
Guohao Wang et al.
NATURE COMMUNICATIONS (2020)
Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
Qingjian Li et al.
NATURE COMMUNICATIONS (2020)
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
Milan Radovich et al.
JAMA ONCOLOGY (2020)
Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis
Jinwoo Son et al.
SCIENTIFIC REPORTS (2020)
Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors
Zhao Zhang et al.
GENOME MEDICINE (2020)
Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
Shengqing Stan Gu et al.
GENOME BIOLOGY (2020)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
Gloria V. Echeverria et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Chemoresistance mechanisms of breast cancer and their countermeasures
Xiwei Ji et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Targeting Cancer Cell Dormancy
Ariadna Recasens et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
Nikolaos Zacharakis et al.
NATURE MEDICINE (2018)
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
Dan Liu et al.
NATURE COMMUNICATIONS (2018)
Long noncoding RNA MALAT1 suppresses breast cancer metastasis
Jongchan Kim et al.
NATURE GENETICS (2018)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure
Gulfem Dilek Guler et al.
CANCER CELL (2017)
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Brian B. Liau et al.
CELL STEM CELL (2017)
Differential network analysis from cross-platform gene expression data
Xiao-Fei Zhang et al.
SCIENTIFIC REPORTS (2016)
OptimalCutpoints: AnRPackage for Selecting Optimal Cutpoints in Diagnostic Tests
Mónica López-Ratón et al.
Journal of Statistical Software (2015)
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival
F. Bertucci et al.
ANNALS OF ONCOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations
Camila Munoz et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2012)
Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis
Otto Metzger Filho et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
Elizabeth A. Mittendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Genomic Grade Index Is Associated With Response to Chemotherapy in Patients With Breast Cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
CYPIBI expression is induced by docetaxel: effect on cell viability and drug resistance
V. G. Martinez et al.
BRITISH JOURNAL OF CANCER (2008)
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati et al.
BREAST CANCER RESEARCH (2008)
Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study
TA Longacre et al.
MODERN PATHOLOGY (2006)
A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin
SA Glynn et al.
BRITISH JOURNAL OF CANCER (2004)
分享论文
